XL-281 (BMS-908662) is an orally active inhibitor for RAF kinase, with IC 50 s of 2.6, 4.5 and 6 nM, for CRAF, B-RAF , and B-RAFV600E, respectively. XL-281 exhibits antitumor activity.
Products | Products > Disease Areas > Cancer | Products > Signaling Pathways > MAPK/ERK Pathway | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Raf
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.